• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Philips inks 11-year enterprise monitoring deal with Jackson Health

Philips inks 11-year enterprise monitoring deal with Jackson Health

June 27, 2018 By Fink Densford

Philips

Royal Philips (NYSE:PHG) said today it inked an 11-year enterprise monitoring deal with Jackson Health System.

Through the deal, the Amsterdam-based company will provide patient monitoring services on a per-patient fee basis, which Philips touted will eliminate up-front costs and allow the health system to standardize patient monitoring across the network.

“For Jackson, patient safety is paramount and trying to balance patient safety with the rapidly changing technology landscape requires innovative business models and a true partnership that will allow us to manage our IT needs, while enhancing our quality of care. This model will assist our drive for operational and clinical excellence through best practices, continuing education, and shared accountability, allowing us to focus on what matters most – empowering our staff to deliver the best possible care to our community,” Jackson Health System CEO Carlos Migoya said in a prepared statement.

The deal will cover services for all of Jackson Health’s hospitals, urgent care centers, primary care and specialty care centers and long-term care nursing facilities, Philips said.

Philips will maintain ownership of the patient care monitoring system and will provide technical support, workflow optimization, education and data management.

“By applying the software as a service model to enterprise patient monitoring in healthcare, Philips and Jackson can re-invent how health systems adopt technology. As an innovative health system, Jackson Health is partnering with us to not only offer the communities they serve the very latest in patient care monitoring systems with predictive analytics, they are pioneering a business model that could have a meaningful impact for other health systems across the country. This model will allow them to manage costs on a per patient basis and future-proof their monitoring technology, all while increasing patient and staff satisfaction through a more seamless monitoring experience,” Philips NA CEO Vitor Rocha said in a press release.

Earlier this month, Philips said it acquired U.K.-based Remote Diagnostic Technologies for an undisclosed amount.

Filed Under: Business/Financial News, Patient Monitoring Tagged With: Philips

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy